Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery
Chemical Biology & Drug Design · 2026-07 · 108 (1)
DOI: 10.1111/cbdd.70365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 23.07.2026. Verfasst von Adedayo Ayodeji Lanrewaju und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban, South Africa. Hauptthemen laut MEDLINE: Antiviral Agents, Drug Delivery Systems, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 378 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, National Research Foundation of South Africa, Water Research Commission.
Abstract (Originalsprache)
The COVID‐19 pandemic highlighted the role of rapid viral mutation and global connectivity in accelerating viral emergence and spread, emphasising the necessity for expedited and adaptable antiviral drug discovery and development. Despite ongoing efforts to develop effective, low‐toxicity therapeutics, the number of antivirals that have achieved clinical approval remains limited. The shortfall is especially significant in developing countries, where access to new antivirals is limited by high prices, few options, import dependence, unstable supply chains and weak purchasing systems. The challenge is further heightened by the emergence of increasingly drug‐resistant variants while vaccines often provide inadequate protection against newly mutated or novel viruses. Consequently, the identification of novel antiviral agents that are both effective and cost‐efficient via innovative strategies for antiviral drug discovery is essential to manage and control viral infections. Therefore, this review examines the different challenges associated with conventional antiviral drugs alongside recent strategies in antiviral drug discovery and development, such as the exploitation of plant secondary metabolites with antiviral properties, advanced microscopy technologies, computer‐aided drug design, artificial intelligence and machine learning, gene‐editing technologies, drug combination therapy and nanotechnology‐enhanced drug delivery systems. Additionally, this study proposes a simple decision‐focused pathway integrating natural products, computation and targeted delivery to guide candidate prioritisation, optimisation and translation from discovery to implementation. While these emerging strategies offer considerable promise, challenges related to validation, toxicity, scalability and equitable access remain important considerations for successful clinical translation. Future research should therefore integrate complementary technologies to accelerate the development of effective antiviral agents against current and emerging viral threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Food Science, Faculty of Applied Science, Durban University of Technology, Durban, South Africa.
ORCID-Profile: Adedayo Ayodeji Lanrewaju, Abimbola Motunrayo Folami, Saheed Sabiu
Förderung
- South African Medical Research Council
- National Research Foundation of South Africa
- Water Research Commission
Zitieren
APA
Lanrewaju, A. A., Folami, A. M., Sabiu, S., & Swalaha, F. M. (2026). Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70365
Vancouver
Lanrewaju AA, Folami AM, Sabiu S, Swalaha FM. Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70365
BibTeX
@article{Lanrewaju2026,
author = {Lanrewaju, Adedayo Ayodeji and Folami, Abimbola Motunrayo and Sabiu, Saheed and Swalaha, Feroz Mahomed},
title = {Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/cbdd.70365}
}
EUVIMED